Naveen Patnaik in politics, Dr. Kancherla Ravindranath in Business, Sania Mirza in Sports among top contenders at ILC Power Brand Indian of the Year 2014.Arvind Kejriwal in Politics, Nandan Nilekani in public service,Sangram Singh in Sports, Shraddha Kapoor in Cinema, Dr Mukesh Batra in Healthcare among the heavyweights at the 5th Annual Indian Affairs India Leadership Conclave’s Indian of the Year awards 2014

 

 

Indian Affairs

Naveen Patnaik in politics, Dr. Kancherla Ravindranath in Business, Sania Mirza in Sports among top contenders at ILC Power Brand Indian of the Year 2014.Arvind Kejriwal in Politics, Nandan Nilekani in public service,Sangram Singh in Sports, Shraddha Kapoor in Cinema, Dr Mukesh Batra in Healthcare among the heavyweights at the 5th Annual Indian Affairs India Leadership Conclave’s Indian of the Year awards 2014. 

 

 

Saturday, May 31st , Mumbai, Maharashtra, India. Post the watershed & historic elections in India where India gave a clear & decisive mandate to the BJP led NDA formation since 1984, the political & economic leadership in India is set to go for a big change as the new government at center is expected to roll out plethora of opportunities & no nonsense approach in policy reforms. While India is awaiting to reinvent itself as a major player in the world, Indian Affairs ( http://www.indianaffairs.tv ), the flagship media outfit of Network 7 Media Group ( http://www.network7mediagroup.in ) asia’s most analytical news media is set to debate on a most relevant theme “Progress or Perish” at the historic 5th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2014. India Leadership Conclave is introducing & benchmarking the new set of excellence awards in the form of Indian of the Year Awards in six prominent categories in Politics, Sports, Business, Cinema, Healthcare & Public Service to be conferred to the leaders who has been at the forefront of India’s success story to be voted by millions of voters to win the race for the prestigious honour.

Announcing the nominations to the Indian Affairs Indian of the year 2014 Award Categories, Satya Brahma, Chairman & Editor-In-Chief of Network 7 Media Group said
“Indian Affairs after a close scrutiny of the moods of the nation decided to recognize the individuals for the remarkable & outstanding contribution in the field of Business, Healthcare, Public Service, Sports, cinema & political leadership. Network 7 Media Group’s eminent Jury members comprising of veterans from different sections of the society selected five nominees based on a meticulous & research driven analytical methodology to throw it open to the public for voting. The idea is to test the moods of the rising Indian intellectual class on whose perception India deserves to crown the Indian of the Year crown in the six important segments, said Satya.

While one can vote via Via Online at http://www.ilc2014.in or via Via Email – Typing the Code & Mail it to myvote@ilc2014.in ( Example if the code is XX, than type XX to ilc2014.in or via Via SMS – Type Your Code & send it to ++ 91 9036065456 ( Example if the code is XX, than type XX & send it to ++ 91 9036065456. Network 7 Media Group will also carry out physical interviews by Indian Affairs Journalists to a sample size of 2.5 Lakh voters in 16 Cities & will be counted in final votings. While only 40 % of weightage are given to Sms/Email/Online/Physical Interviews to gauge the mood of the nation, 60 % purely rests on merits & Jury Members decision to give the real justice & make it transparent in Indian Affairs’s quest to find the real winners.

The nomination for the Indian Affairs Indian of the year 2014 leadership awards in the following categories.

Indian Affairs Indian of the year Business Leadership

Nominees

1.Mr. Kumar Mangalam Birla, Chairman, Aditya Birla Group ( Code IOTY1)
2.Dr. Kancherla Ravindranath, CMD, Global Hospitals Group ( Code IOTY2)
3.Mr. Niranjan Hiranandani. Co Founder & MD, Hirandani Group ( Code IOTY3)
4.Mr. Adi Burjorji Godrej. Chairman, Godrej Group ( Code IOTY4)
5.Mr. Anil Dhirubhai Ambani, Chairman, Anil Dhirubhai Ambani Group ( Code IOTY5)

Indian Affairs Indian of the year 2014 Political Leadership

Nominees

1.Dr. Jayaprakash Narayan, President, Lok Satta party. ( Code IOTY6)
2.Mr.Rajendra Kumar Misra, President, Nav Bharat Democratic Party ( Code IOTY7)
3.Mr.Arvind Kejriwal, Founder, Aam Admi Party ( Code IOTY8)
4.Mr.Naveen Patnaik, Chief Minister, Odisha ( Code IOTY9)
5.Mr.Manohar Parikar, Chief Minister, Goa.( Code IOTY10)

Indian Affairs Indian of the year 2014 Sports Leadership

Nominees

1.Ms.Sania Mirza, Tennis ( Code IOTY11)
2.Ms.Saina Nehwal, Badminton ( Code IOTY12)
3.Mr.Shikhar Dhawan, Cricket ( Code IOTY13)
4.Mr.Sangram Singh, Wrestling ( Code IOTY14)
5.Mr.Sandeep Singh, Hockey. ( Code IOTY15)

Indian Affairs Indian of the year 2014 Public Service

Nominees

1.Mr.Nandan Nilekani, Former Chairman, UIDI ( Code IOTY16)
2.Mr.T.V. Mohandas Pai, Vice President, The Bangalore Political Action Committee. ( Code IOTY17)
3.ADR India, ( Code IOTY18)
4.Mr.Arvind Kejriwal, Ex CM, Delhi. ( Code IOTY19)
5.Ms.Kiran Bedi, Former IPS Officer.( Code IOTY20)

Indian Affairs Indian of the year 2014 Cinema

Nominees

1.Ms Vidya Balan, Actress ( Code IOTY21)
2.Ms.Kangana Ranaut, Actress ( Code IOTY22)
3.Ms.Yami Gautam, Actress. ( Code IOTY23)
4.Ms.Sonakshi Sinha, Actress ( Code IOTY24)
5.Ms.Shraddha Kapoor,Actress ( Code IOTY25)

Indian Affairs Indian of the year 2014 Healthcare Leadership

Nominees

1.Dr Pratap Reddy, Chairman, Appolo Group. ( Code IOTY26)
2.Dr Devi Shetty, Chairman, Narayan Hridalaya. ( Code IOTY27)
3.Dr Mukesh Batra, Chairman, Dr Batras ( Code IOTY28)
4.Dr Jagga Shetty, Former Drug Controller of Karnataka. ( Code IOTY29)
5.Dr Ramakant Panda, Chairman, Asean Heart Institute ( Code IOTY30)

The set of Awards for the coveted & prestigious Indian Affairs Indian of the year 2014 Awards will be presented in Mumbai on 18th July 2014 after the seminar.

For Details, Conclave Secretariat, Network 7 Media Group, Unit No. 53, 2nd Floor, Aditya Industrial, Estate, CTS No. 1068 – C, Plot No.444 ( P ), Devrukhkar Wadi, Chincholi Bunder Road, Malad ( W ), Mumbai – 400 064. Phone: + 91 22 4248 1234 / 4248 1235. Email : sangeeta.singh@network7mediagroup.com http://www.ilc2014.in Phone: + 91 22 4248 1234 / 4248 1235. Email : sneha@dreamzactivations.com , anish@dreamzactivations.com

India to debate on “Progress or Perish” at 5th Annual India Leadership Conclave & Indian Affairs Leadership Awards 2014

Banner Press

India to debate on “Progress or Perish” at 5th Annual India Leadership Conclave & Indian Affairs Leadership Awards 2014

Mumbai to host Asia’s Biggest Leadership Title by veteran industry Experts on inflation, Employment, Cultural Emergencies, Political & Economic Leadership & a staggering indian economy paving the way for a vibrant leadership in coming years

Saturday, May 10, 2014, Mumbai, Maharashtra,  India. In what is perceived to be a change catalyst or a game changer, illustrious Network 7 Media Group’s ( www.network7mediagroup.in ) Indian Affairs Media outfit (www.indianaffairs.tv ), Asia’s biggest analytical news media will be hosting the much awaited annual affair in its 5th year, the 5th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2014 ( www.ilc2014.in )in the commercial capital of india in Mumbai on  Friday, 18th July 2014 under a powerful theme on “Progress or Perish” to be debated, analyzed & addressed by Asia’s most promising voices & industry stalwarts on a variety of subjects ranging from politics to cultural, economics to social. After being highly successful in last 4 editions, the much awaited India Leadership Conclave 2014 is expected to be be attended by more than 250 business tycoons, political leaders, policy makers, social reformers, diplomats, media professionals followed by the Indian Affairs Indian of the year Awards in various categories in addition to regular categories thrown to public for voting with a credible nomination methodology.

“At a time when India is experiencing an unexpected political, special & cultural challenges post-independence,  67 years has passed, yet india at the strike of midnight on August 14, 1947 India began its experiment of democracy against all odds, the present regime in political & economic leadership is on test as india is beginning to experiment its model, structure & fabrics” says Satya Brahma, Chairman & Editor-In-Chief of Network 7 Media Group who also chairs the organizing committee of the 5th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2014. The Nation today stands divided on which way the political leadership is going & where there are far more bigger issues to address like FDI, Economic Reforms, Poverty, Unemployment, Basic Healthcare, Inflation, Ironically politically parties are busy scoring on trivial & personal animosity in the run up to 2014 General Election, Irrespective of which formation india will choose, the message is loud & clear, that the incoming leadership at the entre will have to find a comprehensive policy reforms to boost staggering indian economy, therefore the theme at the conclave is aptly titled as “Progress or Perish” , Said Satya Brahma while announcing the 5th edition of India Leadership Conclave.

Keeping its objective to deliberate critical issues, India leadership Conclave will address on a far reaching significant issues by the speakers who will assemble to address the Nation. Indian Affairs will also recognize & felicitate  the ILC Power Brand, Indian of the Year Awards & 30 more categories in various sectors to recognize the shining stars of Indian leaders & companies who has demonstrated rare display of marching ahead with a hostile economy.

Indian Medical Technology & Diagnostic Market need Innovations, access,availability and affordability. Indian Challenge is the penetration to the untapped & unorganised rural market : Dr G.S.K. Velu

Indian Medical Technology & Diagnostic Market need Innovations, access,availability and affordability. Indian Challenge is the penetration to the untapped & unorganised rural market : Dr G.S.K. Velu

Eminent Medical Technologist & Visionary Dr G.S.K. Velu of Trivitron Group receives rare recognition at Pharmaleaders 2013 Meet

 Image

Thursday, January 09, 2014,Mumbai,Maharashtra,India. Innovations are required in Smaller towns,cities, rural areas – largely untapped – disruptive, frugal innovations to improve access, availability, and affordability of Healthcare to address enormous Challenges in India.While Challenges exists in all four critical sectors such as pharmaceuticals, healthcare services medical education & medical technology, Medical Technology  remains the most neglected segment in India said Dr G.S.K. Velu,Founder Chairman of Trivitron Group Companies at the historic 6th Annual Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2013 held at Mumbai on 27th December .The 6th Annual Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards 2013 ( www.pharmaleaders2013.com  ) organized by illustrious Network 7 Media Group’s Pharmaleaderstv, Asia’s most analytical news media in healthcare communications ( www.pharmaleaders.tv  ) under the theme “Incredible Pharmaleaders 2013, Billion Dreams – Pushing India’s Growth Agenda” was successfully organized at Mumbai on 26th December 2013 with several leading national & global brands in pharmaceuticals & healthcare were felicitated & recognized for their outstanding contribution to the healthcare industry & medical profession by the eminent jury members of Network 7 Media Group. More than 300 professionals of the healthcare industry & medical experts attended to the historic global platform.

Taking the exceptional & remarkable progress by the young & dynamic visionary chairman of  Dr G.S.K. Velu of Trivitron Group of Companies initiatives & foray in medical technology & diagnostic industry, the jury member of the Network 7 Media Group & Pharmaleaders comprising of eminent personalities in public life, the consensus reached at honoring Dr G.S.K. Velu for his pioneering work in original innovation & taking the brand india’s image to the global platform. While the coveted “Entrepreneur of the year  2013 Award” was conferred to Dr. G.S.K. Velu for achieving rare success at the younger age in providing exceptional directions to the group companies leading from the front, Dr Velu’s pet outfit Medfort Maxivision Hospitals was declared winner in the coveted “Emerging Hospital Group 2013” category. Mayank Gandhi, Member National Executive, Aam Admi Party accompanied by the Editor-In-Chief of the Pharmaleaders Satya Brahma conferred the prestigious & coveted recognition to the first generation entrepreneur.

In a release to media, Dr G.S.K. Velu of Trivitron Group of Companies said “Trivitron Group is well-set to triple its manufacturing business  across different geographies within next 4 years & growing focus on innovation that helps build  range of products at affordable price. India can be a Global Med Tech Hub like Pharma with the right Eco System. Single Speciality Healthcare Services have a unique relevance owing to economies of scale and out-of-hospital convenience. Innovations in these areas will help achieve Health Security for All by 2020. I am  humbled by this rare & prestigious recognition & I accept this honour on behalf of 1000 employees”. 

In the key note address to the healthcare experts, policy makers & medical professionals & academician who were present at the 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2013 in the evening session, visionary Dr G S K Velu flabbergasted the delegates on the much awaited talk on Innovation and Advancements in Medical Devices and Single Specialty Healthcare Services – An India  Perspective as he emphasized that the Indian Medical technology, expertise and quality healthcare is set to grow phenomenally in next 5 years ahead of Japan & United States.

Creating the Largest Medical Technology company of Indian Origin, Dr Velu stressed that the Indian Medical Technology  Market is presently at approx. USD 5 Billion contributes to less than 2% of Global Market CAGR 4.4% & 60 % Revenue in Top 4 Medical Technology Segments coming  from  Medical Imaging, In Vitro Diagnostics, In Vitro Cardiology Diagnostics& Gastroenterology. Innovations are required in all four segments of Healthcare to address enormous Challenges in India & while challenges exists in all four sectors, Medical Technology  remains the most neglected segment in India.The Market Size of the Indian medical technology from  325 Billion USD  in 2012 is expected to cross  the Market Size 448 Billion USD in 2017. India is uniquely placed as it has huge market with increasing middle class population & growing private hospital sector providing improved accessibility, Increased Government Spending Planned by State and Central Government, Overseas companies investing in India to set up R & D units, Increasing Joint ventures and agreements, Overseas aid assisted projects to improve healthcare infrastructure, Regulations to improve market for domestic manufacturers, India can be a Global Med Tech Hub like Pharma with the right Eco System,Single Speciality Healthcare Services having a unique relevance owing to economies of scale and out-of-hospital convenience & only Innovations in these areas will help achieve Health Security for All by 2020. However India’s growth trajectory can lose its gear due to Low per capita expenditure,Developing government policies and infrastructure,Large population having low affordability,Lack of indigenous manufacturing,Academic know-how is not well developed in this sector,Support system for R & D not available Regulatory policies may slow down the development of the market,Unorganized market for medical disposables,Lack of regulations, specifications – leading to spurious products,Implementation Western  Regulatory systems blindly  may slow down access and affordability  in rural areas

To the credit of Dr Velu, the notable achievement includes Process 100 Million tests a year, Caters to more than 10,000 laboratories, hospitals & nursing homes,Assists 20,000 consultants,Market Leader in South and West India,Over 85 state-of-art-laboratories 1400 Collection Centers across India, Middle East & Africa,Direct Laboratory Presence in over 15 countries in South Asia, Middle East and Africa,NABL and,or CAP Accreditation for all Central Lab facilities,Technology leader encompassing all IVD technologies with over 4000 variety of investigations,India’s Most Reputed Multinational Chain of Diagnostic center with direct laboratory presence in over 15 Countries,Strategic Minority Private Equity Investment by Warbug Pincus Capital,Best Diagnostics Service Provider in India in 2009 – Frost & Sullivan.  As a Pioneers in Eye Care Technology who introduced LASIK SURGERY IN INDIA in 1996, A Medfort  Initiative, National chain of Eye care and Diabetic Daycare Hospitals,15 State of the Art Eye Hospitals in 5 Cities operational . Plans 20 cities presence by 2015 ,State-of-the-art facilities for Diagnostics, Treatment, Surgery and MR, Victus Femtosecond Laser Cataract Technology –A  100% Hands Free, Blade-Free Technology, 1,80,000 Ocular Surgeries performed so far, 24,00,000 patients screened and treated so far & US-FD, CE approved Technologies

A first generation entrepreneur of over 25 years of experience in healthcare segment, who changed the way the medical technology and diagnostics industry works today, bringing them within the reach of medical practitioners across India, Dr Velu,Founder and Managing Director, Trivitron Group of Companies (the largest medical technology company of Indian origin) & Co Founder and Vice Chairman, Metropolis Healthcare(one of the largest diagnostic laboratory chains in Asia),Founder and Chairman, MedfortHospitals( a network of diabetes care and vision care hospitals),Founder and Director, Alliance Medicorp (Chain of dialysis and dental care) did his education in  Bachelor’s degree in Pharmacy from the Birla Institute of Technology and Science (BITS), Pilani, MBA from Loyola Institute of Business Administration and a Doctorate from IBAM, Kolkata he worked with different global organizations gaining experience in medical technology. In 1997, Trivitron was founded by Dr.Velu and tied up with several world leaders in medical technology to cater to over 20 medical specialties across India. He also established the Trivitron Medical Technology Park, South Asia’s first state-of-the-art medical technology manufacturing facility and the Trivitron Innovation Center, a center of excellence for biomedical research & development and design at IIT Madras.

A visionary, Dr. Velu changed the diagnostics field from a highly fragmented industry that served as purely backhand function, into one that plays a leading role in healthcare today. His efforts united leading diagnostics laboratories across the country under the Metropolis banner to set the highest standards of service.His latest venture Medfort is a chain of single specialty ambulatory care hospitals across the country that will soon link some of the nation’s best doctors and technicians with cutting edge technology and international accreditation ensuring that patients get the very best care while continually setting the bar higher in terms of consistent healthcare delivery.

 

About Dr G S K Velu’s Trivitron Group Companies

 

ü  Largest Medical Technology Company of Indian Origin

ü  A multi-modality product company offering products/ solutions / services that are affordable and accessible by the entire population class

ü  8manufacturing facilities that are GLP, GMP certified and spread across Chennai, Mumbai, Pune and Finland, marking our local and international presence

ü  Deployment of state-of-the-art concepts like lean manufacturing, frugal engineering to reduce overall manufacturing costs helping us retain a competitive edge.

ü  Products manufactured through synergies with local and global manufacturers are sold to the local markets and exported to over 165 countries.

ü  5 innovation centres in partnership with India’s leading technical and medical education institutes backed with state-of-the-art technologies

ü  20 % of the revenues invested in R&D to bring forward products that are of low cost, functionally better and technologically superior

ü  12 Warehouses ensuring finest inventory management through processes that prescribe to automation across the entire value chain

ü  25 offices

ü  1000 employees

ü  160  countries

ü  12 warehouses

ü  8 manufacturing  facilities

ü  5 innovation centres

ü  1,200 channel partners

ü  35,000+ installations

 

Noted Cosmetic Dermatologist Dr. Chytra.V.Anand storms into Pharmaleaders Powerbrand 2013,Voted as “India’s Most Respected Cosmetic Dermatologist 2013”

Noted Cosmetic Dermatologist Dr. Chytra.V.Anand storms into Pharmaleaders Powerbrand 2013,Voted as “India’s Most Respected Cosmetic Dermatologist 2013”

Kosmoderma Founder Dr. Chytra.V.Anand crowned the coveted Award for skincare innovations, Aesthetic Medicine services, , Ethical Medical Practices, Standard Operating Protocols, Quality Systems & building first Indian skincare clinic to innovate MediSpa concept.

Dr Chytra low 

Monday,6th January 2013,Mumbai, Maharashtra,India : The chase to select the best out of the best & select the brand & name that mattered most in the ever evolving & growing skincare practice in india ended at the Asia’s most awaited 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2013 organised by the illustrious Network 7 Media Group’s Pharmaleaders Magazine (www.pharmaleaders.tv ), Asia’s most analytical news media in healthcare communications on Friday, 27th December 2013 in the commercial capital of India. Dr. Chytra.V.Anand, Founder, CEO & Chief Cosmetic Dermatologist of Kosmoderma Skin & Laser Clinic was declared winner in the category of “India’s Most Respected Cosmetic Dermatologist 2013” ending the suspense wChytrae 3 million people in 22 states in tier 1 & tier 2 cities in the various sections of india voted to chose the winner in nomination to the top five well known Cosmetic Dermatologists in India.

In the nomination category were the five finalists such as Dr. Malavika Kohli, CEO & Founder, Skin secrets, Dr. Apratim Goel, CEO & Founder, Goel’s Cutis Skin Studio, Dr. Chetana Kumar, Director, Laser Cosmetics, Dr. Shuba Dharmana, CEO & Founder,Le’jeune Medspa & Dr.Chytra V Anand, Founder, CEO & Chief Cosmetic Dermatologist of Kosmoderma Skin & Laser Clinic, shortlisted by the Network 7 Media Group’s esteemed panel members & furtChytra approved by the Pharmaleaders jury members. Dr.Chytra V Anand not only pulled larger number of votes via sms, email & physical interviews that were conducted to access the mood of the nation by the Network 7 Media Group, Chytra also received maximum votes by the independent jury in the final stage. The historic 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2013 was attended by more than 300 delegates that comprised of top doctors, executives from the healthcare companies & policy makers. Mayank Gandhi, Member National Executive, Aam Admi Party accompanied by the Editor-In-Chief of the Pharmaleaders Satya Brahma & Anjali Damania,Convenor of Maharashtra Aam Admi Party conferred the prestigious & coveted recognition to the India’s Most Respected Cosmetic Dermatologist 2013. Dr.Chytra V Anand  in a power packed glittering award evening.   

Elated & Excited to hear Chytra name at the stage, Dr.Chytra V Anand said “ This recognition means a great degree of honKosmoderma & prestige as the award methodology & selection criteria was credible & my responsibilities increase manifold with this rare recognition & it will motivate my mission to achieve path breaking research in skincare innovations currently undergoing at my firm Kosmoderma”.

Cosmetic Dermatology is an ever-evolving field of science that is non-essential medicinal service. The idea of beautification , moulding , creating, the artistry and skill level involved to be cutting edge in this field is an exciting prospect in itself… To make this art and science combination available to the Indian masses at affordable pricing and at the same time not compromise on the quality of care and medical ethics is what drives me. My vision is to make Kosmoderma Clinics the Gold standard & trendsetter in Aesthetic Medicine& Cosmetic Dermatology. This is my dream and this has set me on my path of pursuit towards providing the best Cosmetic Dermatology services in India equivalent if not superior to that found abroad and on the world platform for such services, Dr Chytra added.

Currently I am leading my team to open Kosmoderma centres of excellence across India, in Chennai, Hyderabad, Mumbai and Delhi. I have a vision of 3 centres per Tier 1 city and 1 centre per tier 2 city.  I am excited to see Kosmoderma evolving from a Cosmetic Dermatology practice to a one-stop wellness centre with integration of Nutrition, Cosmetic Surgery and Rehabilitative Skin & Hair Medicine. To reach the grass roots and offer Kosmoderma services across India, we are in the midst of developing a Kosmoderma Associate Physician program, wChytrae dermatologists are offered special training in cosmetic dermatology at Kosmoderma Academy and then without having to invest heavily into all equipment’s, are able to refer patients to Kosmoderma centres of excellence at various cities. This way we are able to reach all levels of Indian clientele and offer safe effective reasonable priced procedures without compromise on technology or quality of care. As part of my endeavKosmoderma to provide the best Cosmetic Dermatology, Aesthetic Medicine services, I have been involved in research of skincare suitable for Indian skin since 2008 and currently have 14 products in the Kosmocare range and am working on research to furtChytra develop scientifically proven, effective skincare for the Indian skin that every Indian or person of colKosmoderma can use safely. I am currently running trials on 4 new products that are meant for effective sun protection to decrease skin damage. Currently these are available at Kosmoderma Clinics and at select leading Cosmetic Dermatologists. In future Kosmocare will be available online post a skinscription by Skype from Kosmoderma doctors and Kosmoderma affiliate program.

I love training doctors to bring them to par with international standards as after being educated in India and in UK & USA, I found that though we are brilliant people, Kosmoderma education standards are not up to par with the West… So in 2007 I started a training academy IAAM to train doctors to bring them up to par with the western doctors in the field of Aesthetic Medicine & Cosmetic Dermatology. After having personally trained over 550 doctors this is a driving passion for me to make sure that all Kosmoderma doctors have a fair playing field and that the global perception of Indian Cosmetic Dermatologists changes.

Kosmoderma is dedicated to medical excellence in the field of Cosmetic Dermatology, with international accreditations and facilities, offering scientifically proven treatments using US FDA & European CE approved technology.

All Kosmoderma products have undergone extensive research and trials. We strive towards technical excellence and are constantly updating Kosmodermaselves so as to deliver world class cutting edge technology to Kosmoderma clients every day. Kosmoderma Aim is to offer result oriented, safe and effective treatments with high standards of quality with exceptional care and service and make it affordable to the Indian consumer.Kosmoderma is proud to have pioneered the first state of art clinics dedicated solely to Cosmetic Dermatology and Medical Aesthetics in Bangalore back in 2006, currently with 5 branches across Bangalore, 1 in Hyderabad with staff strength of 50+. The recent JVs between Kosmoderma and otChytra healthcare providers will see the opening of Kosmoderma Skin Clinics inside specialist healthcare centers across the country starting with Chennai, Mumbai, Pune and Delhi.

Dr Chytra V Anand founded Kosmoderma Clinics in 2006 as a one person operation with the vision to create an enterprise, which quickly grew to have 3 employees. In 2007 Chytra opened the 2nd clinic in Indianranagr Bangalore and the team grew to a size of 7. In 2008, the flagship in Lavelle Road was opened with the company strength growing to 15. Recognising the need to spread the availability of services across the city and to be avilable to the people, the 3rd clinic was opened in Whitefiled area in 2010 and a 4th centre of excellence at JP Nagar in 2012. The team grew incorporating Dermatologists, Aesthteic Physcians and Medical Aestheticians and the entire area of Bangalore is now covered.

As CEO, Chytra is involved with overseeing the growth of the company and maintaining of quality. Chytra heads a team of 50+ and leads them to excel on a daily basis. As a Consultant dermatologist Chytra consults patients at Kosmoderma Clinics and is sought after from patients across the world and all walks of life.After years of research by Dr Chytra, Kosmoderma has its own in house skin care brand Kosmocare. This has entered Kosmoderma into the FMCG market segment.

Under Chytra’s  guidance, expansion plans are underway to have a flagship clinic in every metro within a year from now and a pan India presence of 25 clinics within the next 3 years. Kosmoderma will achieve this with strategic partnering with otChytra healthcare brands who like us have a vision of providing speciality healthcare services and a mission to aggressively cover the subcontinent in a very short time span catering to the needs of the masses who demand the latest treatments and best of services in terms of healthcare. Recognising E-commerce, from Jan 2014 Kosmoderma will be offering skype consults and online sale of Kosmocare.

Kosmoderma is the first Indian Cosmetic Dermatology centre to have its own app (Acne app) available to help acne prone individuals developed personally by Dr Chytra and Chytra team.In summary: Dr Chytra Anand is the CEO of the Company. Chytra plays a pivotal role in strategy, business growth and Quality of Services & Outcome Standalone clinics, Strategically Partnered clinics, Branded skin care products, Leveraging Information Technology are strategic and business growth outcomes from Chytra efforts.

Service Manuals, Ethical Medical Practices, Standard Operating Protocols, Quality Systems are outcomes arising from Chytra passion to quality of service and outcomes From 2006 to 2013, Kosmoderma has grown from 1 clinic, 1 person to 6 clinics with a team of 50+ under the guidance of Kosmoderma CEO Dr Chytra V Anand. Chytra vision to make Kosmoderma a team work based enterprise as opposed to single person entity has seen Chytra create an outstanding team of leaders and an enterprise par excellence.

Keeping with the philosophy of spreading knowledge, in 2007, Dr Anand founded the International Academy of Aesthetic Medicineto train doctors in the field of Cosmetic Dermatology as Chytra realized that doctors in India did not have enough exposure to Cosmetic Dermatology in regular practice and required additional specialized training. Under Chytra guidance the academy conducts intensive hands on training cKosmodermases for doctors from around the globe. Chytra has personally trained over 750 doctors in Aesthetic Medicine procedures at Chytra academy and is credited with pioneering Aesthetic Medicine & Cosmetic Dermatology training in India. The Academy has attracted students from India, UK, Sri Lanka, Europe, Dubai, Africa, Singapore, Thailand and Malaysia and is considered a top-notch training facility.

In 2010, keeping with the international trend, Kosmoderma launched the MediSpa concept. Under this beauty was merged with medicine to provide maintenance services for skin, hair and body. It was the first of its kind in India.

In 2012, Kosmocare a skin care brand made by a FDA approved lab in Thailand and a GMP approved lab in India. Currently tChytrae are 14 products in the range and trials for 6 more are currently underway, with 5 more formulations under research. This is now a business vertical for Kosmoderma.Realising the necessity to grow at a quicker pace without seeking external funding yet, strategic partnerships have been formed with otChytra healthcare providers like MotChytrahood a VC funded 150 Cr company that is in the process of expansion across South India in the IVF, birthing sector wChytrae Kosmoderma is opening a shop in shop model to provide services in Chennai & Hyderabad. Realising the importance of being available to the masses, Kosmoderma has partnered with Express Clinics a primary healthcare provider with 6 outlets in Bangalore, 10 each in Pune, Mumbai and Delhi to provide Dermatological and Cosmetic Dermatology services at its centre on an out sKosmodermaced basis. With this Kosmoderma will forray into Pune, Mumbai & Delhi sectors.

With these 2 strategic Healthcare Partnerships, Kosmoderma will have a pan Indian presence by 2014 end.In Nov 2013, a centre dedicated to pregnant and lactating women and women with hormonal imblanaces was opened at CMH road to specially cater to this segement with specialised services incorporating allopathy, Ayurveda and homeopathy.In 2013 Kosmoderma Academy was launched for dedicated constant training of Kosmoderma staff and regular updates to maintain standardised quality across all centres.With increase in dollar rate vs Rs, the Indian dermatological climate changed with doctors compromising on quality and purchasing cheaper non FDA , CE approved lasers to cater to the demand leading to inferior results. To try to curb this dilution of quality and to bring in a wider network of doctors under the Kosmoderma umbrella, the Kosmoderma Affiliate , Associate Program has been launched, wChytrae dermatologists and allied physicians like OBGYN, Endocrinologists and GP’s refer their patients to Kosmoderma for Cosmetic Dermatology services. The dermatologists are provided specialised training at Kosmoderma Academy and their patients are treated for them by Kosmoderma staff. Thus dermatologists who are unable to invest into their equipments are able to use Kosmoderma services and still be independent practitioners. Through this venture we have been able to offer quality care without the dermatologists having to turn towards non FDA,CE approved technology and extend the reach of Kosmoderma to a wider audience. This has increased Kosmoderma referral rate and added to revenue of the company and increased Kosmoderma target audience reach. Realising the potential on internet, Kosmoderma is the first Cosmetic dermatology company in India to offer an app service for acne patients. Using this app, acne patients can keep abreast of the latest in the developments in acne therapy. It is currently available for androids and the IOS version will soon be launched.

Dr Anand’s pet project is to standardise and regulate the cosmetic dermatology industry to prevent quackery and abuse of this medical field by non-qualified personnel. She is consulting with deemed universities in Karnataka to create a Diploma Course in Aesthetic Medicine for postgraduates to better prepare the doctors for practise in the Cosmetic industry. She is currently working on a course curriculum for doctors, nurses, and aestheticians. The aim is to introduce these courses from 2015. She has sent a proposal to the Karnataka Govt to regulate the Cosmetic dermatology sector through the Karnataka Medical Council and Health Ministry.

Noted Surgical Gastroenterologist & Global Hospitals Founder Dr. Kancherla Ravindranath crowned at 6th Annual Pharmaceutical Leadership Summit & Awards 2013

Noted Surgical Gastroenterologist & Global Hospitals Founder Dr. Kancherla Ravindranath crowned at 6th Annual Pharmaceutical Leadership Summit & Awards 2013

Image

Dr. Kancherla Ravindranath led Global Hospitals Group voted India’s Best Managed Healthcare Chain 2013 & Founder Dr. Kancherla Ravindranath awarded Healthcare Visionary of The Decade in individual Jury

 

Thursday, January 02, 2014, Mumbai, Maharashtra, India. 6th Annual Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards 2013 ( www.pharmaleaders2013.com ) organized by illustrious Network 7 Media Group’s Pharmaleaderstv, Asia’s most analytical news media in healthcare communications ( www.pharmaleaders.tv ) under the theme “Incredible Pharmaleaders 2013, Billion Dreams – Pushing India’s Growth Agenda” was successfully organized at Mumbai on 26th December 2013 with several leading national & global brands in pharmaceuticals & healthcare were felicitated & recognized for their outstanding contribution to the healthcare industry & medical profession by the eminent jury members of Network 7 Media Group. More than 300 professionals of the healthcare industry & medical experts attended to the historic global platform.

Dr. Kancherla Ravindranath led Global Hospitals Group voted India’s Best Managed Healthcare Chain 2013 & Founder Dr. Kancherla Ravindranath awarded Healthcare Visionary of The Decade at the glittering award ceremony. While Dr Ravindranath was voted by the jury members of the Network 7 Media Group in an individual category, Global Hospitals Group received the rare distinction of winning the coveted & prestigious “India’s Best Managed Healthcare Chain 2013” by the people of india in the voting category after reaching to the top five finalists declared by the jury members of Pharmaleaders Group. Global Hospitals Group received the maximum number of votes of a sample size of 5 million votes that were thrown to public for voting via sms,email & physical interviews conducted by the Pharmaleaders media in 22 states & 5 Nations. Global Hospitals Group emerged out as a clear winner beating the biggest healthcare chains in india & abroad such as Apollo Hospitals Group, Fortis Healthcare, Care Hospitals, Manipal Hospitals Group. At a time when Healthcare Innovations in india is struggling to make its impact due to regulatory constraints, lack of healthcare insurance & high cost of infrastructure & consultant’s professional fees, Global Hospitals is clearly not compromising in quality healthcare & carved out a niche for itself in the Managed Healthcare added Satya.

“The rise of Global Hospitals Group in India having its presence in Hyderabad,Mumbai,Bengaluru & Chennai with world class specialized medical aid in areas ranging from diagnosis to multi-organ transplantation, from simple procedures to complex surgeries, international expertise and state–of-the-art infrastructure caught the attention of the people’s mind while voting” said Satya Brahma, Chairman & Editor-In-Chief of Pharmaleaders Group. Global Hospitals is India’s leading and the fastest growing super specialty care and multi-organ transplantation hospital. Pioneers in performing transplantation surgeries, Global Hospitals has to its credit many trailblazing achievements made possible by combining research, teaching and patient care.

In a communication to Pharmaleaders, Dr. Kancherla Ravindranath, CMD, Global Hospitals Group said “ Global Hospitals Group is the creation of meeting the complex medical treatments of the people of india & providing world-class medical services with latest infrastructure in our each Hospitals, I feel humbled & elated to receive the award from the Pharmaleaders Jury specially when people of india voted us as India’s Best Managed Hospital Chain”. 

Dr. Kancherla Ravindranath, is a world-renowned expert in Surgical Gastroenterology, and the founder of Global Hospitals Group – acknowledged as India’s fastest growing chain of tertiary care multi super specialty hospitals. Under Dr. Ravindranath’s visionary leadership and guidance, Global Hospitals Group has become the premier and niche healthcare center that is in to performing high-end surgeries, such as the first ever liver, heart, twin kidney and bone marrow transplants in Andhra Pradesh and multiple such cutting edge and pioneering surgeries in India. Currently, with eight world class tertiary care Hospitals in Chennai, Bengaluru & Hyderabad, and soon Mumbai centre opening up, today Global Hospitals has grown to be acknowledged as the world’s most comprehensive centre for Liver & Pancreas Diseases and Transplantation. While working in some of UK’s top medical institutions, witnessing the hardships of Liver transplant patients and their painstaking ordeal, spending huge amounts of money, Dr. Kancherla Ravindranath realized the urgent need for a Liver transplant facility in India. Deeply touched by the plight of hundreds of patients’ and inspired by his late Father’s advice to come back to serve India, Dr. Ravindranath relinquished his very successful practice in UK and returned to India to establish Global Hospitals. Global Hospitals is India’s leading and the fastest growing super specialty care and multi-organ transplantation hospital. Pioneers in performing transplantation surgeries, Global Hospitals has to its credit many trailblazing achievements made possible by combining research, teaching and patient care. Global Hospitals constantly strive for quality and innovation while excelling in advanced technology and modern facilities that are crucial to the delivery of high quality medical care, Global Hospital’s  doctors, nurses and technicians has indeed made Global Hospitals a place of highly specialized expertise.

Mr. C. Chandrasekhar, Executive Director – Marketing, Global Hospitals Group received the award at the hand of Mayank Gandhi, Member, National Executive, Aam Admi Party in the presence of Satya Brahma, Chairman & Editor-In-Chief of the Pharmaleaders Group

Historic 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Awards 2013 focused to give Aam Admi of India affordable medicines & Quality healthcare to rural india at Pharmaleaders 2013 Meet

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

Mayank Gandhi of Aam Admi Party & Satya Brahma of Pharmaleaders gave away prestigious honors & coveted awards to the shining stars of the Indian Pharmaceutical & Medical Professionals.

 

30th December 2013, Monday, Mumbai, Maharashtra, India: in a sequel to the sixty days of the voting by the Indian masses to select the best of the best in the final five nominees in various important categories & individual nonvoting categories, Pharmaleaders ( www.pharmaleaders.tv ) felicitated top performers in the healthcare industry & medical professionals in Mumbai on Friday,27th December 2013 at the historic 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2013 ( www.pharmaleaders2013.com ) at the hand of Mayank Gandhi, Member, National Executive of the Aam Admi Party. Organised by Pharmaleaders, Asia’s leading healthcare media in healthcare communications & a division of Network 7 Media Group, The platform witnessed more than 300 professionals of the healthcare industry.

Satya Brahma, Chairman & Editor-In-Chief of Pharmaleaders in the opening address lambasted the union government for the faulty healthcare reforms & policy paralysis. In a scathing attack to the UPA regime, NPPA, Health Ministry, Ministry of Chemicals & Fertilizers, Satya highlighted the series of issues neglected by the authorities & blamed the central government for not listening to the long-standing demands of the sensitive healthcare industry in DPCO logjam, FDI in Pharmaceuticals & the widening gap of the government & the vast majority of Indian masses who are deprived of the basic healthcare needs. The highlight of the seminar was the panel discussion on “Ethics in Medical Profession” where country’s top doctors & industry debated on the decline of ethics in medical profession & reached at the consensus that the industry & doctors must work closely to build a strong models to promote the dignity of the profession.

Addressing the industry leaders & leading faces of the medical profession, Mayank Gandhi, Chief Guest of the evening urged the industry to provide affordable medicines to the Aam Admis & criticized the government of not bringing industry friendly reforms. Mayank stressed the need of a clean politics & higher ethical standards of the rulers & launched a series of attack to the policy makers who underestimated the power of the Aam Admis. The arrogance of the legislators & Parliamentarians will no longer be tolerated as india is now prepared to give a befitting reply to the rulers if legislators failed to the demands of the masses.

The Evening Award ceremony was marked by the entry of the volunteers of the Aam Admi Party at the historic summit. Anjali Damania, Maharashtra State Convenor of the Aam Admi Party joined with Mayank Gandhi & Satya Brahma in the inaugural lamp lighting ceremony followed by the National Anthem in the packed house where the who’s & Who’s of the Indian healthcare industry were present. The Chief guest of the Pharmaleaders awards evening Mayank Gandhi accompanied by the Editor-In-Chief of the Pharmaleaders Satya Brahma conferred the prestigious & coveted titles to the leading faces of the Indian healthcare industry. The winners at the 6th Annual Pharmaceutical Leadership Summit & Awards are as following.

Voting Nomination Category Winners:

Rising Company of the year 2013

1.Galpha Laboratories Ltd.

Emerging Business Leader of the Year 2013

2.Dr Rajeev Modi

MD, Cadila Pharmaceuticals Ltd

3.Emerging Business Woman of The Year 2013

Ms. Nidhi Saxena

Founder & CEO, Karmic Lifesciences

4.Dynamic Entrepreneur of the Year 2013

Mr. Prakash Guha

MD, Zuventus Healthcare Ltd

5.India’s Most Respected Company by Medical Practitioners 2013

Zuventus Healthcare Ltd

6.India’s Best Managed Healthcare Chain 2013

Global Hospitals Group

7.Multinational Company of the year 2013

Abbott India Ltd

8.India’s Most Admired Company in Healthcare IT Solutions 2013

Infinite Computer Solutions (India) Ltd.

9.India’s Most Respected Cosmetic Dermatologist 2013

Dr.Chytra. V. Anand,

Founder, CEO & Chief Cosmetic Dermatologist, KOSMORDEMA

10.India’s Most Admired Company in CRAMS Market 2013

Akums Drugs & Pharmaceuticals Ltd

11.Emerging Company of the Year 2013

Menarini India Private Limited

12.Women Entrepreneur of the Year 2013

Dr. Nilyini G, Founder CEO, Blu Skin Cosmetology

13.CEO  of the year 2013

Mr. Rehan A. Khan

Managing Director, Abbott India

14.India’s Most Admired Company in Corporate Governance 2013

Aurobindo Pharma Ltd

15.Brand of The Year 2013

DOLO

16.Rising Brand of The Year 2013

Newbona (Akumentis Healthcare Ltd)

17.India’s Most Admired Pharma Company 2013

Alkem Laboratories Ltd.

18.India’s Fastest Growing Pharma Company 2013

Menarini India Private Limited

19.India’s Most Respected Healthcare Group To Work For 2013

Emcure Pharmaceuticals Ltd

20.India’s Fastest Growing Company in Contract Manufacturing 2013

Akums Drugs & Pharmaceuticals Ltd       

Non-Voting Category Winners :

 Image

ImageImageImageImageImageImageImageImageImageImageImageImage

ImageImageImageImageImageImageImageImageImageImageImageImage

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

Pharmaleaders Award History – Glorious Moments

Originally launched in 1999 as the Pharma Business & Technology Excellence Awards, these were first produced by the PHARMA BUSINESS & TECHNOLOGY MAGAZINE as a means of honoring innovation in pharmaceutical marketing, corporate governance and research and development & Lifetime Achievements category. Pharma Excellence Awards were produced by PBT Awards in India and expanded to recognize global corporate citizenship and individual achievements.As PBT Magazine wes discontinued, the task was taken up by the Management of Pharma Leaders Magazine. Over the Years, the awards was re-evaluated and recast to focus more on scientific accomplishments in industry and academic pharmaceutical research. The awards have been presented and at a sold-out gala award night. Since the institution of Leadership Awards, over 200 industry executives and leading academic scientists from around the world have been honoured. At a time when the pharma industry is facing some tough times—and the old way of doing things just won’t work, Our Expert Judges roll out the selection methodology to felicitate the top honours. An independent panel of prominent society and industry leaders have been judging these awards. Winners have been selected via various processes & judging are based on information provided by the nominees. Finalists are notified in advance – in writing. The final winners are announced at the awards evening.

Image

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

 

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

PRVIOUS AWRAD WINNERS :

  1. 1.   Late Shri Parvinder Singh, Ranbaxy –Chairman, Ranbaxy Labs Ltd, 1999
  2. 2.   Shri Desh Bandhu Gupta,Chairman, Lupin Ltd – 1999
  3. 3.   Shri K.Anji Reddy, Chairman, Dr Reddy’s Labs Ltd – 1999
  4. 4.   Shri Devinder Pal, Management Consultant. 1999
  5. 5.   Shri Samprada Singh, Chairman, Alkem Labs Ltd.
  6. 6.   Shri Ajit Singh, Chairman, ACG Worldwide,
  7. 7.   Shri I.A.Modi, Chairman, Cadila Pharmaceuticals Ltd.
  8. 8.   Shri Vikram Aima, CMD, Ochoa Labs Ltd.
  9. 9.   Shri Habil F Khorakiwala.Chairman, Wockhardt Ltd.
  10. 10.               Shri Raghavendra Rao, Chairman, Orchid Pharmaceuticals Ltd.
  11. 11.               Shri Dilip Sanghvi, CMD, Sun Pharmaceuticals Ltd.
  12. 12.               Dr Anjali Mukherjee, CEO, Health Total.
  13. 13.               Shri Sujit K Singh, Chairman, Shreya Life Sciences Ltd.
  14. 14.               Shri Vinod Singh, Chairman, Genom Biotech Ltd.

Winners of 2nd Annual Pharmaceutical Leadership Summit 2009 : Excellence Awards.

  1. 1.     V.S.Reddy, Managing Director, British Biologicals. (India’s most Admired Neutraceutical Company)
  2. 2.     Ms Anju Gupta, Managing Director, VHB Life Sciences Ltd. (Most technically & scientifically advanced Pharmaceutical Manufacturing unit of the year).
  3. 3.     S.K Singh, Managing Director, Cachet Pharmaceuticals Pvt. Ltd (Emerging Company of the year Award)
  4. 4.     Dilip Surana, Managing Director, Microlabs Ltd. (Company of the Year).
  5. 5.     Shri Suresh Kare, Chairman, Indoco Remedies Ltd. (Life Time Achievement Award).
  6. 6.     R.C.Bhagat, Chairman, VHB Life Sciences Ltd. (Lifetime Achievement Award).
  7. 7.     Samprada Singh, Chairman, Alkem Labs Ltd. (Lifetime Achievement Award)
  8. 8.     Mr Manohar Kothari, Managing Director, Indo German Pharma Equip Pvt Ltd. (Life Time Achievement Award) Dr Himadri Sen,
  9. 9.     President, R&D, Ranbaxy Ltd (Excellence in “NDDS”& Generics)
  10. 10.                        Sri Ajit Singh, Chairman & Sri Jasjit Singh,MD, ACG World Wide (Lifetime Achievement Award).
  11. 11.                        Sri Jagdish Saxena, Chairman & MD, Elder Pharmaceuticals Ltd (Lifetime Achievement Award).
  12. 12.                        Mr Malvinder Mohan Singh,Chairman,MD & CEO,Ranbaxy Ltd (Dynamic Enterpreneur of the year)
  13. 13.                        Sri Kaushik Desai ,Director& CEO Global Pharmatech (Excellence in Pharma Profession)
  14. 14.                        Dr P.M Naik, Project Director, Zydus Cadila Ltd (Excellence in Pharma Profession)
  15. 15.                        Dr Desh Bandhu Gupta, Chairman, Lupin Ltd (Lifetime Achievement Award).
  16. 16.                        Mr C.P.Bothra, Managing Director, Medreich Group (India’s Most trusted Export Company of the year)
  17. 17.                        Mr N.K.Singh, CMD, Galpha Labs Ltd. (India’s Fastest growing Pharmaceutical Company 09)
  18. 18.                        Ms Anju Gupta, MD, VHB MEDISCIENCES LTD (India’s Youngest MD & CEO)

 

Winners of 3rd Annual Pharmaceutical Leadership Summit 2010 : Excellence Awards.

  1. 1.     Businessman of the Year 2010 Shri Malvinder Mohan Singh, Group Chairman, Fortis
  2. 2.     Businesswoman of the Year 2010 – Dr.Villoo Morawala-Patell, Founder and CMD, AVESTHAGEN LIMITED
  3. 3.     Dynamic Entrepreneur of the Year 2010, Shri Dilip Surana, CMD, Microlabs Ltd.
  4. 4.     India’s Best Pharma OTC Company of the Year 2010- Abbott Ltd
  5. 5.     India’s Best Nutrition & Neutraceuticals Co of the Year 2010 – Dr Anjali Mukerjee’s Health Total
  6. 6.     Best Pharma Company of the Year 2010 – Abbott Ltd,
  7. 7.     Pharma CSR Organisation of the Year 2010. Wockhardt Foundation
  8. 8.     Pharma Professional of the Year 2010 –  , Shri Tapan Ray, Director-General, OPPI. Shri Kewal Handa, MD, Pfizer & Wyeth Ltd. Shri Deepak Naik, Managing Director, Eisai Pharma Ltd
  9. 9.     Lifetime Achievement Award of 2010. Dr.Y K Hamid, Chairman Cipla Ltd,Shri Samprada Singh, Alkem Labs Ltd. Shri I.A.Modi, Chairman,Cadila Pharmaceuticals Ltd. Shri Joseph D’souza, Chairman, Oswolrld. Best Brand of the Year 2010. Volini & Revital,
  10. 10.                        Best Company in R & D Excellence 2010 – , Bharat Biotech International Ltd.
  11. 11.                        India’s Most Admired Surgeon Of the Year 2010, Dr Ramakant Panda, VC, Asian Heart Institute
  12. 12.                        India’s Fastest growing retail Pharmacy Chain 2010 Trust Chemists & Druggists Ltd
  13. 13.                        Excellence in Pharmacy Profession of the Year 2010 Dr Bharatesh R Jagashetty, Drug Controller of Karnataka
  14. 14.                        Excellence Innovators in Blood and Biological Products of the Year 2010 Synergy Diagnostics Pvt Ltd India’s Most Watched Company of the Year 2010 Elder Pharmaceuticals Ltd.
  15. 15.                        Company of the Year 2010 (SME) Galpha Laboratories Ltd
  16. 16.                        Excellence in Bulk Drug and Exports, Hetro Drugs Ltd
  17. 17.                        Emerging Company of the Year 2010 Samarth Pharma Pvt Ltd
  18. 18.                        India’s Most Admired Pharma Company of the year 2010 Pfizer Ltd
  19. 19.                        Hottest Exports Company of the Year 2010, Bry Air Asia Pvt Ltd
  20. 20.                        Research Scientist of the year 2010, Dr Rashmi Barbhaiya, CEO & MD, Advinus Therepeutics Ltd, Computer Literacy Programs for Masses – ST ANGELOS COMPUTER LTD.

 

4th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012.

1. Business Leader of the Year 2011: Mr Kewal Handa, Managing Director, Pfizer India .

2. Business Woman of the Year 2011 (Gen-Next Pharma Leader): Mrs Aditi Kare Panandikar, Whole Time Director, Indoco Remedies .

3. Dynamic Entrepreneur of the Year 2011: Dr Krishna Ella, CMD, Bharat Biotech.

4. Pharma OTC Company of the Year 2011: Ranbaxy Global Consumer Healthcare.

5. India’s Most Admired Nutrition & Neutraceuticals of the Year 2011: Revital Woman & Abbott Healthcare.

6. Company of the Year 2011: Venus Remedies.

7. Pharma CSR Organisation of the Year 2011: Ranbaxy Labs.

8. Pharma Professional of the Decade:

     1. Dr Ajit V. Dangi, CEO & President, Danseen Consulting      2. Mr Ranjit Shahani, Vice-Chairman & MD, Novartis India      3. Narayan Gad, CEO, Formulations, Panacea Biotech  

9. Brand of the Year 2011: Revital&Volini.

10. Innovative R & D Company of the Year 2011: Bharat Biotech International.

11. Emerging Brand of the Year: B-COLENRANGE of Galpha Labs.

12. India’s Most Admired Foundation in Social Innovation: Right to Vision Programme of Wockhardt Foundation.

13. Pharma Achiever of the Year in SME: Dr. Rege’s Laboratories.

14. India’s Most Admired Company in Blood and Biological Products 2011: Synergy Diagnostics Pvt.

15. India’s Most Admired Pharma Company 2011: Microlabs.

16. India’s Most Watched Company of the Year 2011: Elder Pharmaceuticals.

17. Emerging Company of the Year 2011: Aanjaneya Lifecare.

18. India’s Most Admired Company in Exports 2011: Genom Biotech Pvt.

19. Research Scientist of the Year 2011: Dr. Rashmi Barbhaiya, MD & CEO, Advinus Therapeutics Pvt.

20. Multinational Company of the Year 2011. (Joint Winners): Pfizer India & Glaxo SmithKline Pharmaceuticals.

21India‘s Most Admired Hospital Chain 2011: Fortis Healthcare.

22. Biotech Research Company of the Year 2011: Adroit Biomed.

23. India’s Most Technically & Scientifically Advanced Pharmaceutical Manufacturing Unit of the Year 2011: Aanjaneya Lifecare.

It is not about Size & Beds but governance in Private Hospitals in India. Indian Hospitals need a major makeover

It is not about Size & Beds but governance in Private Hospitals in India. Indian Hospitals need a major makeover

Cost Reduction, improving quality of care and access for patients are challenges as Global Hospitals, Apollo Hospitals Group, Fortis Healthcare, Care Hospitals & Manipal Hospitals compete to win coveted India’s Most Best Managed Healthcare Chain 2013

Image

Saturday, November 23, 2013, Mumbai, Maharashtra : India’s medical tourism boom—a $1 billion business that is growing by 30% a year is being regarded by the analysts & experts as one of the fastest & growing sector in healthcare services worldwide as india’s top private hospitals have expanded their healthcare services remarkably both in size & geographies. Health services in India have to be affordable because their patients are poor and typically pay 60 percent of their medical costs out of pocket & without healthcare insurance in place, Indian Hospital majors are facing the heat of price reduction & globalizing healthcare standards. As Healthcare Industry in india mainly the hospital chains are beginning to change their approach, Pharmaleaders ( www.pharmaleaders.tv ), Asia’s most analytical news media in healthcare has nominated top five hospitals in india such as Global Hospitals, Apollo Hospitals Group, Fortis Healthcare, Care Hospitals & Manipal Hospitals for public voting to determine who has the edge in corporate HR & Managed Healthcare in the category of “India’s Most Best Managed Healthcare Chain 2013” at the historic sixth edition of Pharmaceutical Leadership Summit & Business Leadership Awards 2013 ( www.pharmaleaders2013.com ). This widely acclaimed meet is held annually to recognize the best amongst the best based on their yearly performances.

The experience of a few innovative Indian hospitals may point the way forward. India’s health care system as a whole has many problems, mainly on the issue of governance & affordable medical care. The quality of doctors, equipment and infrastructure has been the hallmark of healthcare excellence in Indian hospital industry & The Indian experience shows that costs can be dramatically reduced and access can be expanded even as quality is improved.

The study point out that  private hospitals deliver medical outcomes comparable to that of good U.S. hospitals, as measured by medical complication rates or post-treatment survival rates. Furthermore, they’re profitable. Even if Indian hospitals paid U.S.-level salaries for all health-care staff, which are as much as 20 times higher, their prices would be one-fifth of U.S. levels. By contrast, hospitals in the United States are uncoordinated, duplicating specialized care without enough volume in most of them to make procedures affordable. Even when hospitals consolidate, the motive is often to gain pricing power over insurance companies rather than to lower costs.The second innovation is shifting responsibility for routine tasks to lower-skilled workers. This leaves doctors free to focus on complicated procedures. Several hospitals have created a tier of paramedic workers with two years of training after high school to perform routine medical jobs. As a result, surgeons, for instance, can perform two to three times as many surgeries as their U.S. counterparts. Compare that with the United States, where hospitals reduce costs by laying off support staff, which shifts mundane tasks such as billing to doctors, who are overqualified for such duties.Finally, the Indian hospitals save money through old-fashioned frugality. They shepherd resources by building hospitals at a fraction of the cost spent in the United States, replacing imported devices with local equivalents costing a fraction of the price or, for example, sterilizing and reusing clamps for open-heart surgery that are routinely discarded after one use in the United States. In contrast to the American fee-for-service model, they often pay their doctors a fixed salary. One hospital sends a daily message to all doctors with the previous day’s financial results, encouraging them to consider the cost-effectiveness of their medical choices. In contrast, U.S. hospitals often resemble luxury hotels, with much wasted space and underutilized equipment. Their doctors, and sometimes even their chief financial officers, are unaware of how much procedures cost.How realistic is it that U.S. hospitals will adopt the Indian model? U.S. hospitals are constrained by regulations and norms unlike those in India. Nevertheless, some progressive U.S. hospitals are adopting some of the practices of our Indian exemplars, and more should follow their example.

India might be the last place on earth where you’d expect to find health care innovation. Government programs have finally brought some infectious diseases under control, but the nation’s ability to meet the basic medical needs of its citizens remains abysmal. Despite robust economic growth over the past two decades, the infant mortality rate is three times higher than China’s and seven times greater than that of the U.S. Of the 2 million Indians in need of heart surgery, fewer than 5% get it. The majority of the country’s estimated 63 million diabetics and 2.5 million cancer sufferers haven’t been diagnosed, let alone treated. Seventy percent of India’s 12 million blind people could be cured by a simple surgery—if it were available to them.

Although India boasts 750,000 doctors and 1.1 million nurses, practitioner density is about one-fourth what it is in the U.S. and less than half that of China. Hospital beds are in short supply, and most medical facilities are dated, cramped, and often unhygienic. In a country where the nominal per capita income is only $1,500 a year, patients typically have to pay 60% of health care expenses from their own pockets. Still, Indians believe that good medical treatment is something everyone should have access to regardless of their ability to pay.

Necessity spawns innovation. Despite the pressing demand and constrained supply, a few relatively new Indian hospitals have devised ways of providing world-class health care affordably—and to scale. These hospitals target well-off patients, which forces them to provide care that meets global quality standards. But their purpose is to serve everyone, including patients with very low incomes, which puts pressure on the organizations to lower costs dramatically. Such a business model scales because the low costs of these hospitals attract large volumes of patients and allow the overall enterprise to be profitable. As a result, the hospitals are able to sustain their operations not through the usual government subsidies, charitable donations, or insurance reimbursements but through their revenues.

The Indian hospitals we studied treat medical conditions that range from problems of the eye, heart, and kidney to maternity care, orthopedics, and cancer. Their charges for most procedures are as much as 95% lower than those at U.S. hospitals. How are some Indian hospitals able to provide such high-quality health care at ultralow prices? The obvious answer—the differential in the cost of labor—does play a role: Cardiothoracic surgeons, nephrologists, ophthalmologists, and oncologists in India earn anywhere from 20% to 74% of what their American counterparts do.

These Five Hospitals put together would constitute more than 30,000 Beds & will excel in healthcare services & the competition is intense as the prices of services of the consultants are increasing posing a challenge to meet the budget of the patients.

As india votes to select the coveted India’s Most Best Managed Healthcare Chain 2013 by public voting, it will be a challenge to crown the one of the five to be declared on 27th December 2013 at Mumbai at Pharmaleaders Incredible Pharmaleaders 2013 Meet where more than 250 healthcare leaders will assemble to discuss healthcare reforms.  

Infinite Computer’s Upinder Zutshi to receive prestigious Business Leader of the Year 2013 (Healthcare & IT)

Infinite Computer’s Upinder Zutshi to receive prestigious Business Leader of the Year 2013 (Healthcare & IT)

 

Healthcare IT Leader Upinder Zutshi selected by the Pharmaleaders Jury for bringing innovations in Healthcare Solutions &delivering greater value with new products and information tools at a lower cost

Image

Friday,22nd November 2013, Mumbai, Maharashtra, India : Healthcare industry worldwide is fast changing with the increase in the healthcare reforms, rising chronic diseases & healthcare companies increasingly passionate in bringing low cost healthcare solutions in various areas to improve the quality of healthcare services by using latest technologies. The 6th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2013 ( www.pharmaleaders2013.com ) organized by Network 7 Media Group’s leading media Pharmaleaders(www.pharmaleaders.tv ) is organizing asia’s most eagerly awaited healthcare summit Incredible Pharmaleaders 2013, Billion Dreams – Pushing India’s Growth Agenda on 27th December 2013 in Mumbai, India has been at the forefront of raising significant issues that is grappling the sector worldwide.

In an announcement to the media, Pharmaleaders declared Upinder Zutshi, the dynamic & visionary IT Leader Upinder Zutshi of Infinite Computer Solutions as the Business Leader of the Year 2013 ( Healthcare & IT) for the remarkable progress made in the healthcare IT domain spearheading Infinite’s global healthcare solutions & establishing dominant leadership acumen. Announcing the coveted title, Satya Brahma, Chairman of the Oeganising Committee of the 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leaders Awards 2013 said “Upinder Zutshi’s continued concentration in bringing affordable healthcare solutions to the wide array of healthcare services & the ability to compete in the fiercely competitive market coupled with the innovation in identifying the needs of the healthcare enterprises resulted in chosing the prestigious title in a non-voting individual category from the top it leaders of the country”. At a time when the global economic slowdown compelling the healthcare players to reduce their healthcare IT budget, Upinder has successfully innovated low cost IT Solutions in hospital and outpatient management, healthcare reform, regulatory compliance, care coordination & management, clinical analytics & business intelligence,icd-10 transition revenue cycle management, elf service & patient engagement, enterprise applications Outsourcing & European North American, Asia Pacific & Middle East Will form the biggest market for Infinite in 2015..”

Reaching out to Pharmaleaders selection & announcement, Upinder Zutshi, CEO & MD of Infinite Computers Solutions said “ It is indeed a big honour & at the same time brings a bigger responsibility on my shoulder to perform better in the healthcare domain. Our total revenue from the overall business in healthcare domain is 18 % & Infinite Computers is confident to double the numbers in coming years as more & more healthcare companies are coming forward to repose faith in our services said Upinder.

Elaborating more on the services, elated Upinder emphasized that Infinite helps health plan organizations focused on delivering greater value with new products and information tools at a lower cost. Our strengths lie in business process improvements, fully managed care implementations and the upgrade of legacy equipment, all while complying with new regulations. Infinite has the edge in Applications that enable Claims Processing, Legacy Systems Modernization,Health Analytics & Business Intelligence,ICD-10 Transition,Healthcare Reform Compliance,Managed Care Product Configuration and Implementation,Quality and Claims Auditing and Reporting. Our solution includes A comprehensive Electronic Medical Records (EMR) Solution for deployment across Clinics and Hospitals in the US,This EMR solution meets the unique needs of primary care, urgent care, occupational medicine, and various other specialties,Automates most of the processes and provides easy access to patient’s clinical information, thereby enhancing the practitioner’s ability to provide premium patient care,EMR system tracks the patient through the entire clinical/ hospital procedures and enables the end-user to generate a comprehensive clinical note, submit claims electronically and maintain patient’s health information and accounts,The system also integrates with the e-RX exchange to facilitate electronic prescriptions directly to the pharmacies& the solution is ONC-ATCB 2011 /2012 certified,EMR also provides interfaces for external laboratories, billing system and pharmacies.

 

It is pertinent here to note that The global healthcare IT market is estimated to reach $56.7 billion by 2017–up from $40.4 billion in 2012–due to the demand for clinical information technology, administrative solutions and services. The primary reasons for growth, according to the report, include the pressure to cut healthcare costs, demand to integrate healthcare systems,High rate of return on investment in healthcare systems, Financial support and incentives from the U.S. government, Medical tourism in the Asian region, Government initiatives, the rise in the aging population, Growing demand of CPOE adoption in order to reduce medication errors, A rise in incidences of chronic disorders.

The rising need to continuously monitor and care for health has increased the global expenditure on healthcare services and products. The trend is also gradually pushing people towards home healthcare products and services, due to their cost efficiency and reliability. This, in turn, is driving the growth of the global home healthcare products and services market. The technological and application developments that have taken place in the home healthcare segment have made them more reliable and globally acceptable. It has also made it feasible for hospitals and patients to get early discharge, and minimize the cost and infrastructure pressures. The growth in certain diseases or medical conditions such as high blood pressure, diabetes, asthma, and other cardiovascular and respiratory diseases, which require continuous monitoring and care, are further driving the home healthcare market growth. Though the global share of the home healthcare equipment market is considerably less, it is growing at a faster CAGR of 9.9% from 2012 to 2018 due to rising technological innovations, especially in the field of home therapeutic equipment. The home healthcare services market, despite its large share, is expected to grow at a CAGR of 7.4% from 2012 to 2018. The main deterrent, restricting the entry of organized players in this segment is dominance of a large number of small regional players, who are offering their services at low prices, and enjoy high customer loyalty. This has in turn, shifted the attention of big players towards the home healthcare equipment market.

Upinder Zutshi will receive the prestigious title of the Business Leader of the Year in Healthcare & IT on Friday, 27th December 2013 in Mumbai, india in a power-packed & glittering award ceremony where Pharmaleaders will felicitate top 40 leaders in different categories